Minocycline: Neuroprotective Mechanisms in Parkinson's Disease

E-ISSN： 1873-4286|10|6|679-686

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.10, Iss.6, 2004-02, pp. : 679-686

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Curcumin: A Potential Neuroprotective Agent in Parkinson's Disease

Current Pharmaceutical Design, Vol. 18, Iss. 1, 2012-01 ,pp. : 91-99

Bentham Science Publishers

Access to resources Recommend Favorite

Alzheimer's Disease-Associated Neurotoxic Mechanisms and Neuroprotective Strategies

Current Drug Targets-CNS & Neurological Disorders, Vol. 4, Iss. 4, 2005-08 ,pp. : 383-403

Bentham Science Publishers

Access to resources Recommend Favorite

Current Evidence for Neuroprotective Effects of Nicotine and Caffeine Against Parkinson's Disease

By Ross G.W.

Drugs & Aging, Vol. 18, Iss. 11, 2001-01 ,pp. : 797-806

Adis International

Access to resources Recommend Favorite

Are Dopamine Receptor Agonists Neuroprotective in Parkinson's Disease?

By Le W-D. Jankovic J.

Drugs & Aging, Vol. 18, Iss. 6, 2001-06 ,pp. : 389-396

Adis International

Access to resources Recommend Favorite

D1 and Functionally Selective Dopamine Agonists as Neuroprotective Agents in Parkinson's Disease

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 5, Iss. 3, 2006-06 ,pp. : 345-353

Bentham Science Publishers

Access to resources Recommend Favorite